JP2008534546A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008534546A5 JP2008534546A5 JP2008503447A JP2008503447A JP2008534546A5 JP 2008534546 A5 JP2008534546 A5 JP 2008534546A5 JP 2008503447 A JP2008503447 A JP 2008503447A JP 2008503447 A JP2008503447 A JP 2008503447A JP 2008534546 A5 JP2008534546 A5 JP 2008534546A5
- Authority
- JP
- Japan
- Prior art keywords
- component
- kit according
- prostate
- administered
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200500452 | 2005-03-31 | ||
| DKPA200500452 | 2005-03-31 | ||
| PCT/EP2006/003194 WO2006103112A2 (en) | 2005-03-31 | 2006-03-31 | Method for treating prostate diseases based on local delivery of active substances |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012258603A Division JP2013067639A (ja) | 2005-03-31 | 2012-11-27 | 活性物質の局所送達に基づく前立腺疾患の治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008534546A JP2008534546A (ja) | 2008-08-28 |
| JP2008534546A5 true JP2008534546A5 (cg-RX-API-DMAC7.html) | 2009-05-21 |
| JP5635231B2 JP5635231B2 (ja) | 2014-12-03 |
Family
ID=35044589
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008503447A Expired - Fee Related JP5635231B2 (ja) | 2005-03-31 | 2006-03-31 | 活性物質の局所送達に基づく前立腺疾患の治療方法 |
| JP2012258603A Ceased JP2013067639A (ja) | 2005-03-31 | 2012-11-27 | 活性物質の局所送達に基づく前立腺疾患の治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012258603A Ceased JP2013067639A (ja) | 2005-03-31 | 2012-11-27 | 活性物質の局所送達に基づく前立腺疾患の治療方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8936809B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1865924B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5635231B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR20140014294A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101160116B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006228675B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2602776C (cg-RX-API-DMAC7.html) |
| DK (1) | DK1865924T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2557988T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE026158T2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL185690A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007011908A (cg-RX-API-DMAC7.html) |
| NO (1) | NO338679B1 (cg-RX-API-DMAC7.html) |
| PL (1) | PL1865924T3 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2404747C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006103112A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200708066B (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140014294A (ko) * | 2005-03-31 | 2014-02-05 | 리드스 에이비 | 유효 물질의 국소 전달을 기본으로 하는 전립선 질병의 치료 방법 |
| MX2011005243A (es) * | 2008-11-27 | 2011-08-08 | Lidds Ab | Uso de carboximetilcelulosa para controlar la eyectabilidad y el tiempo de solidificacion de las composiciones que comprenden una o mas ceramicas biorreabsorbibles. |
| AU2012240131B2 (en) * | 2011-04-05 | 2017-07-20 | Edge Therapeutics | Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow |
| RU2519407C2 (ru) * | 2011-09-21 | 2014-06-10 | Виктор Павлович Горелов | Способ трансуретральной резекции предстательной железы, предшествующий брахитерапии рака простаты |
| GB201318858D0 (en) * | 2013-10-25 | 2013-12-11 | Glaxosmithkline Biolog Sa | Calcium fluoride compositions |
| GB201318862D0 (en) * | 2013-10-25 | 2013-12-11 | Glaxosmithkline Biolog Sa | Calcium fluoride compositions |
| WO2016028774A1 (en) | 2014-08-19 | 2016-02-25 | The Regents Of The University Of California | Implants for localized drug delivery and methods of use thereof |
| JP6758325B2 (ja) | 2015-06-04 | 2020-09-23 | クリティテック・インコーポレイテッド | タキサン粒子およびその使用 |
| CN114767860A (zh) | 2016-04-04 | 2022-07-22 | 克里蒂泰克公司 | 实体肿瘤治疗方法 |
| CA3063420A1 (en) | 2017-06-09 | 2018-12-13 | Crititech, Inc. | Treatment of epithelial cysts by intracystic injection of antineoplastic particles |
| AU2018284247B2 (en) | 2017-06-14 | 2020-04-30 | Crititech Inc. | Methods for treating lung disorders |
| CA3076919A1 (en) | 2017-10-03 | 2019-04-11 | Crititech, Inc. | Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer |
| WO2020061291A1 (en) * | 2018-09-20 | 2020-03-26 | Biovena Science, Llc | Flutamide microsphere-based arterial embolization for treating prostate disorders |
| US11911499B2 (en) | 2019-11-07 | 2024-02-27 | Resurge Therapeutics, Inc. | System and method for prostate treatment |
| US11338119B2 (en) * | 2020-03-20 | 2022-05-24 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
| US11344526B2 (en) * | 2020-03-20 | 2022-05-31 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
| CA3171976A1 (en) * | 2020-03-20 | 2021-09-23 | Carlos Schuler | Implantable drug delivery devices for localized drug delivery |
| US11173291B2 (en) * | 2020-03-20 | 2021-11-16 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
| US11957654B2 (en) | 2022-01-29 | 2024-04-16 | Resurge Therapeutics, Inc. | Treating benign prostatic hyperplasia |
| US11602516B1 (en) | 2022-01-29 | 2023-03-14 | Resurge Therapeutics Inc. | Treating benign prostatic hyperplasia |
| EP4469108A1 (en) * | 2022-01-29 | 2024-12-04 | Resurge Therapeutics, Inc. | Benign prostatic hyperplasia treatment system |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4474813A (en) * | 1980-10-24 | 1984-10-02 | Schering Corporation | Pharmaceutical preparations comprising flutamide |
| US5614206A (en) * | 1995-03-07 | 1997-03-25 | Wright Medical Technology, Inc. | Controlled dissolution pellet containing calcium sulfate |
| US5795330A (en) | 1996-10-10 | 1998-08-18 | Etex Corporation | Mixing device |
| CA2268156C (en) * | 1996-10-16 | 2007-05-29 | Etex Corporation | Bioceramic compositions |
| US6391336B1 (en) | 1997-09-22 | 2002-05-21 | Royer Biomedical, Inc. | Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| US5972384A (en) * | 1997-10-01 | 1999-10-26 | University Of Maryland, Baltimore | Use of biologically active glass as a drug delivery system |
| CA2378486A1 (en) | 1999-08-05 | 2001-02-15 | Takashi Kurasawa | Osteogenesis promoter sustained-release paste |
| US6497901B1 (en) * | 2000-11-02 | 2002-12-24 | Royer Biomedical, Inc. | Resorbable matrices for delivery of bioactive compounds |
| US6645974B2 (en) * | 2001-07-31 | 2003-11-11 | Merck & Co., Inc. | Androgen receptor modulators and methods for use thereof |
| US20030147936A1 (en) * | 2002-02-07 | 2003-08-07 | Velayudhan Sahadevan | Prostatic hormonal implants treatment of prostate cancer |
| US8404681B2 (en) * | 2003-03-24 | 2013-03-26 | Luitpold Pharmaceuticals, Inc. | Xanthones, thioxanthones and acridinones as DNA-PK inhibitors |
| GB0307082D0 (en) * | 2003-03-27 | 2003-04-30 | Gyne Ideas Ltd | Drug delivery device and method |
| JP4927535B2 (ja) * | 2003-04-03 | 2012-05-09 | ジェシー エル エス オウ | 腫瘍を標的指向化する薬物を封入した粒子 |
| US20040224000A1 (en) * | 2003-05-05 | 2004-11-11 | Romano Deghenghi | Implants for non-radioactive brachytherapy of hormonal-insensitive cancers |
| PL1680089T3 (pl) * | 2003-10-22 | 2014-03-31 | Lidds Ab | Kompozycja zawierająca biodegradowalną ceramikę hydratującą do kontrolowanego dostarczania leków |
| KR20140014294A (ko) * | 2005-03-31 | 2014-02-05 | 리드스 에이비 | 유효 물질의 국소 전달을 기본으로 하는 전립선 질병의 치료 방법 |
-
2006
- 2006-03-31 KR KR1020137034233A patent/KR20140014294A/ko not_active Ceased
- 2006-03-31 RU RU2007140243/14A patent/RU2404747C2/ru active
- 2006-03-31 CA CA2602776A patent/CA2602776C/en not_active Expired - Lifetime
- 2006-03-31 US US11/910,162 patent/US8936809B2/en active Active
- 2006-03-31 WO PCT/EP2006/003194 patent/WO2006103112A2/en not_active Ceased
- 2006-03-31 HU HUE06724133A patent/HUE026158T2/en unknown
- 2006-03-31 DK DK06724133.1T patent/DK1865924T3/en active
- 2006-03-31 JP JP2008503447A patent/JP5635231B2/ja not_active Expired - Fee Related
- 2006-03-31 AU AU2006228675A patent/AU2006228675B2/en not_active Ceased
- 2006-03-31 MX MX2007011908A patent/MX2007011908A/es active IP Right Grant
- 2006-03-31 KR KR1020077022037A patent/KR101380402B1/ko not_active Expired - Fee Related
- 2006-03-31 ES ES06724133.1T patent/ES2557988T3/es not_active Expired - Lifetime
- 2006-03-31 PL PL06724133T patent/PL1865924T3/pl unknown
- 2006-03-31 EP EP06724133.1A patent/EP1865924B1/en not_active Expired - Lifetime
- 2006-03-31 CN CN2006800100200A patent/CN101160116B/zh not_active Expired - Fee Related
-
2007
- 2007-09-03 IL IL185690A patent/IL185690A0/en active IP Right Grant
- 2007-09-19 ZA ZA2007/08066A patent/ZA200708066B/en unknown
- 2007-10-30 NO NO20075490A patent/NO338679B1/no unknown
-
2012
- 2012-11-27 JP JP2012258603A patent/JP2013067639A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007518805A5 (cg-RX-API-DMAC7.html) | ||
| NZ580226A (en) | Dimer compounds as inhibitors of iap | |
| ES2557988T3 (es) | Método para tratar enfermedades de próstata basado en el suministro local de principios activos | |
| PE20061122A1 (es) | Composiciones que incluyen hierro | |
| RU2012111235A (ru) | Комбинированная терапия композициями наночастиц таксана и ингибиторами хэджхог | |
| UA95955C2 (ru) | Ингибиторы обратной транскриптазы вич | |
| JP2007523049A5 (cg-RX-API-DMAC7.html) | ||
| MY146111A (en) | Acylaminopyrazoles as fgfr inhibitors | |
| CO6400138A2 (es) | Compuesto anticancerígeno y composición farmacéutica que lo contiene | |
| AR067824A1 (es) | Compuestos de acido boronico y ester boronico inhibidores de la proteasoma, composiciones farmaceuticas que los contienen y usos de los mismos para el tratamiento del cancer. | |
| JP2010507593A5 (cg-RX-API-DMAC7.html) | ||
| RU2004126950A (ru) | Использование выделяющих co соединений при изготовлении лекарственного средства для лечения воспалительных заболеваний | |
| EP2147927A3 (en) | Use of 131i-tm-601 for the diagnosis and treatment of gliomas | |
| WO2009017838A3 (en) | Combinations of jak-2 inhibitors and other agents | |
| NZ597830A (en) | Methods and compositions for treating cancer comprising abiraterone acetate and prednisone | |
| JP2009506054A5 (cg-RX-API-DMAC7.html) | ||
| EA200600524A1 (ru) | Способы лечения эндометриоза | |
| JP2006502236A5 (cg-RX-API-DMAC7.html) | ||
| WO2007084560A8 (en) | INHIBITORS OF TNFα, PDE4 AND B-RAF, COMPOSITIONS THEREOF AND METHODS OF USE THEREWITH | |
| EP1749830A4 (en) | CURCUMOL DERIVATIVES, COMPOSITION COMPRISING THE SAME, AND THEIR USE FOR THE PRODUCTION OF MEDICAMENTS | |
| ATE505488T1 (de) | Modulator von coagulationskaskaden und fibrinolytischen kaskaden | |
| BRPI0518231A2 (pt) | derivados de 2-amido-4-feniltiazol, o respectivo preparo e a respectiva aplicaÇço em terapÊutica | |
| PT1583538E (pt) | Utilização da 3-metoxi-pregnenolona para a preparação de um medicamento destinado a tratar as doenças neurodegenerativas | |
| JP2012512157A5 (cg-RX-API-DMAC7.html) | ||
| UA96969C2 (en) | Acylaminopyrazoles as fgfr inhibitors |